Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases (Feb 2020).

Article Link: https://www.sciencedirect.com/science/article/pii/S0925443920300612

Journal: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Authors and Affiliations: Paul D. Kruithof a, Sergey Lunev a, Sheila P. Aguilar Lozano a, Fernando de Assis Batista a, Zayana M. Al-dahmani a, Jaap A. Joles b, Amalia M. Dolga c, Matthew R. Groves a, Harry van Goor d

a Univeristy of Groningen, Department of Pharmacy and Drug Design, the Netherlands

b University Medical Center Utrecht, Department of Nephrology and Hypertension, the Netherlands

c

University of Groningen, Department of Pharmacy, Molecular Pharmacology, the Netherlands

d

University Medical Center Groningen, Department of Pathology and Medical Biology the Netherlands


Previous
Previous

Evaluation of toxicity of gadolinium-based contrast agents on neuronal cells (May 2020).

Next
Next

Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation (Jan 2020).